VeriMomasiaticoside hamilelikte güvenli mi?
No harmonised CLP reproductive classification found for asiaticoside (CAS 16830-15-2). Regulatory/authoritative safety assessments (CIR/SCCS/Harmonised CLP) do not list reproductive hazards for asiaticoside, and peer‑reviewed literature reports pharmacology (wound healing/dermatologic effects) rather than reproductive toxicity (PubMed, PubChem). Therefore default hazard/mechanism/exposure scores are 0. Sources consulted: PubChem, PubMed, ECHA/CosIng listings; no CIR or SCCS reproductive concerns identified.
Pregnancy-safe products containing asiaticoside
Related ingredients
Frequently asked questions
- asiaticoside hamilelikte güvenli mi?
- No harmonised CLP reproductive classification found for asiaticoside (CAS 16830-15-2). Regulatory/authoritative safety assessments (CIR/SCCS/Harmonised CLP) do not list reproductive hazards for asiaticoside, and peer‑reviewed literature reports pharmacology (wound healing/dermatologic effects) rather than reproductive toxicity (PubMed, PubChem). Therefore default hazard/mechanism/exposure scores are 0. Sources consulted: PubChem, PubMed, ECHA/CosIng listings; no CIR or SCCS reproductive concerns identified.
- asiaticoside emzirirken güvenli mi?
- No evidence in regulatory databases or peer‑reviewed literature that asiaticoside causes reproductive or lactation-related toxicity or systemic maternal effects that would contraindicate breastfeeding. Asiaticoside is a relatively large polar glycoside (limited oral/topical systemic bioavailability reported in dermal contexts), and no demonstrated mechanism for transfer into breast milk was identified (PubMed, PubChem, ECHA/CosIng).
- asiaticoside bebek cildi için güvenli mi?
- No reproductive/toxic effects specific to infants were identified. Given asiaticoside is a triterpenoid glycoside with limited reported systemic absorption after topical application, hazard and mechanistic scores remain 0. Exposure score raised to 1 for 0–3 yr skin because immature barrier and higher surface‑area‑to‑weight can increase percutaneous uptake (general dermal pharmacokinetic principle); however no data show significant systemic exposure in infants.
- VeriMom asiaticoside nasıl puanlıyor?
- VeriMom asiaticoside'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte asiaticoside yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.